PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > Formulary Search > PAD Profile : Caffeine citrate - Neonatal apnoea
PAD Profile : Caffeine citrate - Neonatal apnoea
Brand Names Include :
Peyona, Fenapin
Traffic Light Status
Status 1 of 2.
Status :
Red
Important
Formulations :
- Infusion
Important Information :
Neonatal team only.
State dose in terms of caffeine citrate to avoid risk of dosing errors.
Caffeine citrate 2 mg = caffeine base 1 mg.
Ampoules for intravenous infusion or oral administration.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 2.
Status :
Red
Important
Formulations :
- Oral solution
Important Information :
Neonatal team only.
Bioavailability of the oral solution is almost 100%.
State dose in terms of caffeine citrate to avoid risk of dosing errors.
Caffeine citrate 2 mg = caffeine base 1 mg
Ampoules for intravenous infusion or oral administration.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
No guidelines returned.
Other Drugs
No drugs returned.
Other Indications
No indications returned.
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
06 November 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.
Associated BNF Codes
04. Central Nervous System
04.04.00. CNS stimulants and drugs used for ADHD